Animal NDC 46066-502-02 Lincomycin
Animal Product Information
Lincomycin Images
Lincomycin Animal Product Labeling Information
The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.
Table of Contents
Description
Lincomycin 300
(lincomycin injection)
For use in swine weighing 300 pounds or more.
For Intramuscular Use in Swine Only
CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Lincomycin 300 contains lincomycin hydrochloride, an antibiotic produced by Streptomyces lincolnensis var. lincolnensis which is chemically distinct from all other clinically available antibiotics and is isolated as a white crystalline solid.
Indications & Usage
INDICATIONS FOR SWINE:
Lincomycin 300 is indicated for the treatment of infectious forms of arthritis caused by organisms sensitive to its activity. This includes most of the organisms responsible for the various infectious arthritides in swine, such as staphylococci, streptococci, Erysipelothrix and Mycoplasma spp.
It is also indicated for the treatment of mycoplasma pneumonia.
Contraindications
CONTRAINDICATIONS:
As with all drugs, the use of Lincomycin 300 is contraindicated in animals previously found to be hypersensitive to the drug.
Residue Warning
Residue Warning: Swine intended for human consumption should not be slaughtered within 48 hours of latest treatment.
User Safety Warnings
Human Warnings: Not for human use. Keep out of reach of children.
General Precautions
CAUTION:
If no improvement is noted within 48 hours, consult a veterinarian.
Adverse Reactions
ADVERSE REACTIONS:
The intramuscular administration to swine may cause a transient diarrhea or loose stools. Although this effect has rarely been reported, one must be alert to the possibility that it may occur. Should this occur, it is important that the necessary steps be taken to prevent the effects of dehydration.
The Safety Data Sheet (SDS) contains more detailed occupational safety information. To report adverse drug events, for technical assistance or to obtain a copy of the SDS, contact Aspen Veterinary Resources at [email protected]. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDA-VETS or online at www.fda.gov/reportanimalae.
Dosage & Administration
DOSAGE AND ADMINISTRATION:
For arthritis or mycoplasma pneumonia - 5 mg per pound of body weight intramuscularly once daily for three to seven days as needed. One mL per 60 lb body weight will provide 5 mg/lb.
For optimal results, initiate treatment as soon as possible.
As with any multi-dose vial, practice aseptic techniques in withdrawing each dose. Adequately clean and disinfect the vial closure prior to entry with a sterile needle and syringe. No vial closure should be entered more than 20 times.
Each mL contains:
Lincomycin hydrochloride equivalent to lincomycin 300mg; also benzyl alcohol 9.45 mg added as a preservative.
How Supplied
HOW SUPPLIED:
Lincomycin 300, 300 mg/mL: For use in swine weighing 300 pounds or more. Supplied in 100 mL multiple dose vial.
Storage And Handling
Store at 20°C - 25°C (68°F - 77°F). Keep from freezing.
Approved by FDA under ANADA # 200-368
Package Label.Principal Display Panel
* The information on this page is for an ANIMAL PRODUCT, please review the complete disclaimer below.